Research Peptides, Defined
Lab suppliers say “research peptide” all the time. Few of them stop to explain it. A clear definition is the first thing a buyer of laboratory material should have.
Below we cover four points. What a peptide is. What turns one into a research peptide. How these compounds are synthesised and checked. And where the research-use label draws its limits.
On this page
Peptides in one paragraph
Link a few amino acids together with peptide bonds and you have a peptide. Proteins use the very same amino acids. What separates the two is size. A chain of about fifty units or less usually counts as a peptide. Anything longer is normally called a protein. Small size and a fixed sequence make peptides exact, repeatable tools for biological study.
The range is wide. GHK-Cu is a tripeptide, built from just three amino acids. Tesamorelin runs to forty-four. Every sequence folds into its own defined structure. That predictability is why a peptide behaves as a reliable input from one experiment to the next.
Where the “research” label comes from
The word “research” refers to the purpose of supply. A research peptide is provided for laboratory and in vitro research use only. It is not intended for people or animals, and it is not meant for treating or diagnosing anything. The molecule is unchanged; only its permitted use is defined.
No medicines regulator, the European Medicines Agency included, has assessed or authorised these materials. They go to qualified researchers and laboratories who are expected to work with them under controlled conditions and within the relevant laws and standards. For that reason NordPeps confirms researcher status before an order and marks every product as research use only.
From resin to powder: production
The usual route is solid-phase peptide synthesis (SPPS). Chemists anchor the first amino acid to a solid resin and add the rest one by one. The finished chain is then cut free and cleaned up. The chemistry is never flawless. Alongside the intended sequence it leaves traces of shortened chains, chains with a missing residue, and altered variants. Those by-products are the reason purification and testing carry so much weight.
The raw product is next purified, most often with preparative HPLC. It is then freeze-dried. The result is a stable lyophilized powder that keeps well in storage and in transit.
Checking quality: purity and identity
Quality rests on two lab techniques. HPLC answers the purity question: how much of the sample is the intended peptide. Mass spectrometry answers the identity question: whether that peptide has the correct sequence. A Certificate of Analysis issued for a specific lot reports both results. Our article on peptide purity explains how to interpret the figures.
Examples studied in labs today
These compounds reach into many corners of biology. The NordPeps catalog lists, for instance, BPC-157 and TB-500 for tissue-repair studies, MOTS-c for metabolic studies, Semax for neuroscience, and NAD+ for work on cellular aging. All of them are sold for in vitro and laboratory use and nothing else.
Frequently asked questions
Is a research peptide a medicine?
No. It is supplied for in vitro and laboratory research alone. No medicines regulator has assessed or authorised it, and it must not be used in people or animals, or for diagnosis or treatment.
How is a research peptide produced?
Usually by solid-phase peptide synthesis. The amino-acid chain is built up on a solid resin, released from it, cleaned up by HPLC and then freeze-dried into a lyophilized powder.
How can a lab confirm a peptide is genuine?
By checking the Certificate of Analysis. HPLC gives the purity. Identity comes from mass spectrometry, or from HPLC run against a reference standard. Both results belong to one lot number, and that number should be the same as the one on the vial.